quinazolines has been researched along with atorvastatin in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Guo, Z; Zhao, H | 1 |
Boerner, JL; Bohin, N; Ge, Y; Irwin, ME; Mueller, KL | 1 |
Brewer, M; Janakiram, NB; Mohammed, A; Rao, CV; Steele, VE; Vedala, K | 1 |
Bi, H; Chen, J; Hou, J; Liu, B; Liu, D; Liu, J; Shi, H; Wen, X; Yuan, J; Yue, L; Zhang, C; Zhang, X | 1 |
Adedoyin, A; Cho, CR; Fox-Bosetti, S; Iwamoto, M; Liu, F; Macha, S; McCrea, JB; Menzel, K; Panebianco, D; Stoch, SA; Zhao, T | 1 |
1 review(s) available for quinazolines and atorvastatin
Article | Year |
---|---|
Medicinal chemistry strategies in follow-on drug discovery.
Topics: Animals; Atorvastatin; Bendamustine Hydrochloride; Benzazepines; Chemistry, Pharmaceutical; Clinical Trials as Topic; Drug Delivery Systems; Drug Discovery; gamma-Aminobutyric Acid; Heptanoic Acids; Humans; Lapatinib; Nitrogen Mustard Compounds; Pregabalin; Pyrimidines; Pyrroles; Quinazolines; Sulfonamides | 2009 |
4 other study(ies) available for quinazolines and atorvastatin
Article | Year |
---|---|
Lipid raft localization of EGFR alters the response of cancer cells to the EGFR tyrosine kinase inhibitor gefitinib.
Topics: Atorvastatin; Benzylamines; beta-Cyclodextrins; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cholesterol; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; ErbB Receptors; Female; Gefitinib; Heptanoic Acids; Humans; Lovastatin; Membrane Microdomains; Phosphorylation; Protein Kinase Inhibitors; Protein Transport; Proto-Oncogene Proteins c-akt; Pyrroles; Quinazolines; Thiophenes | 2011 |
Multitargeted low-dose GLAD combination chemoprevention: a novel and promising approach to combat colon carcinogenesis.
Topics: Adenomatous Polyps; Animals; Antineoplastic Combined Chemotherapy Protocols; Atorvastatin; Carcinogenesis; Cell Proliferation; Chemoprevention; Colon; Colonic Neoplasms; Cytokines; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Eflornithine; Female; Gefitinib; Heptanoic Acids; Intestine, Small; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Molecular Targeted Therapy; Pyrroles; Quinazolines | 2013 |
Atorvastatin overcomes gefitinib resistance in KRAS mutant human non-small cell lung carcinoma cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Atorvastatin; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Class I Phosphatidylinositol 3-Kinases; Drug Resistance, Neoplasm; Drug Synergism; Extracellular Signal-Regulated MAP Kinases; Gefitinib; Heptanoic Acids; Humans; Lung Neoplasms; Mice; Mutation; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-raf; Proto-Oncogene Proteins p21(ras); Pyrroles; Quinazolines; ras Proteins; Signal Transduction; Xenograft Model Antitumor Assays | 2013 |
Drug-Drug Interaction of Letermovir and Atorvastatin in Healthy Participants.
Topics: Acetates; Adult; Atorvastatin; ATP Binding Cassette Transporter, Subfamily G, Member 2; Drug Interactions; Female; Healthy Volunteers; Humans; Neoplasm Proteins; Quinazolines | 2022 |